<DOC>
	<DOCNO>NCT01116882</DOCNO>
	<brief_summary>The primary objective trial compare acute safety long term outcome hospital cardiac surgery on-site ( SOS hospital ) hospital without cardiac surgery on-site ( non-SOS hospital ) patient ischemic heart disease treat elective percutaneous coronary intervention ( PCI ) ( stable angina , acute coronary syndrome , non-Q wave MI ) present non-SOS hospital .</brief_summary>
	<brief_title>Percutaneous Coronary Intervention ( PCI ) Outcomes Community Versus Tertiary Settings</brief_title>
	<detailed_description>The MASS COMM trial prospective , multi-center , randomize , control two-arm trial PCI perform non-SOS hospital ( non-SOS-PCI arm ) versus PCI perform SOS hospital ( SOS-PCI arm ) . The trial design reject null-hypothesis inferiority , thereby show non-inferiority non-SOS-PCI arm SOS-PCI arm . Specifically , 3690 subject enrol multi-center , randomize , control trial ( RCT ) , eligible subject consent randomized 3:1 ratio non-SOS hospital PCI perform either enrol non-SOS hospital ( 3 chance 4 ) correspond SOS hospital ( 1 chance 4 ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Subject least 18 year old . 2 . Subject require single multivessel percutaneous coronary intervention ( PCI ) de novo restenotic target lesion ( include instent restenotic lesion ) . 3 . Subject 's lesion ( ) ( ) amenable stent treatment currently available FDAapproved bare metal drug elute stent . 4 . Subject acceptable candidate elective , urgent emergency coronary artery bypass graft ( CABG ) . 5 . Subject clinical evidence ischemic heart disease term positive functional study , document symptom . 6 . Documented stable angina pectoris [ Canadian Cardiovascular Society Classification ( CCS ) 1 , 2 , 3 , 4 ] , unstable angina pectoris document ischemia ( Braunwald Class IBC , IIBC , IIIBC ) , nonST segment elevation myocardial infarction , document silent ischemia . 7 . Subject willing able undergo percutaneous intervention SOS hospital , randomize SOS study arm . 8 . Subject treat physician agree subject comply followup evaluation . 9 . Subject informed nature study agree provision provide write informed consent approve Institutional Review Board/Ethics Committee respective clinical site . 10 . The target lesion ( ) ( ) de novo restenotic ( include instent restenotic ) native coronary artery lesion ( ) great 50 less 100 % stenosis ( visual estimate ) , target lesion acute ( less 1 month ) total occlusion evidence clinical symptom . 11 . Target lesion ( ) ( ) locate infarct ( treated primary PCI ) noninfarctrelated artery 70 % great stenosis ( visual estimate ) 72 hour follow ST segment elevation myocardial infarction ( STEMI ) . Lesions treat PCI 72 hour follow STEMI would subject protocol inclusion/exclusion criterion list exception target lesion 70 % great stenosis may treat without symptom abnormal stress test ) . 1 . The patient pregnant breastfeeding . 2 . Evidence STEMI within 72 hour intend treatment infarct relate noninfarct related artery . 3 . Cardiogenic shock presentation current hospitalization . 4 . Left ventricular ejection fraction le 20 % . 5 . Known allergy : aspirin , clopidogrel ( Plavix ) ticlopidine ( Ticlid ) , heparin , bivalirudin , stainless steel , contrast agent ( adequately premedicated ) . 6 . A platelet count le 75,000 cells/mm3 great 700,000 cells/mm3 WBC le 3,000 cells/mm3 . 7 . Acute chronic renal dysfunction ( creatinine great 2.5 mg/dl less 150Âµmol/L ) . 8 . Subject currently participate investigational drug device study complete primary endpoint clinically interfere current study endpoint . ( Note : Trials require extend followup product investigational , since become commercially available , consider investigational trial ) . 9 . Prior participation study . 10 . Within 30 day prior index study procedure , subject undergone previous coronary interventional procedure kind . Note : This exclusion criterion apply postSTEMI patient . 11 . Stroke transient ischemic attack within prior 3 month . 12 . Active peptic ulcer upper gastrointestinal bleeding within prior 3 month . 13 . Subject active sepsis . 14 . Unprotected leave main coronary artery disease ( stenosis great 50 % ) . 15 . In investigator 's opinion , subject comorbid condition ( ) could limit life expectancy le one year , limit subject 's ability participate study comply followup requirement impact scientific integrity study . 16 . Subject normal insignificant coronary ( i.e . coronary lesion ( ) less 50 % stenosis ) . 17 . Any target vessel evidence : excessive thrombus ( e.g . require target vessel thrombectomy ) tortuousity ( great 60 degree angle ) make unsuitable proper stent delivery deployment , heavy calcification . 18 . Any target lesion require treatment device percutaneous transluminal coronary angioplasty ( PTCA ) prior stent placement ( e.g . limited , directional coronary atherectomy , excimer laser , rotational atherectomy , etc. ) . 19 . Any lesion locate saphenous vein graft , however , lesion locate within native vessel access graft eligible . 20 . The target vessel `` last remaining '' epicardial vessel ( e.g . great 2 nontarget epicardial vessel bypass grafts territory [ present ] totally occlude ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>PCI</keyword>
	<keyword>heart disease</keyword>
	<keyword>ischemic heart disease</keyword>
</DOC>